PhaseRx OverviewPhaseRx Research & Development
Research & Development expenses for PZRXQ.
Quarterly R&D Expenses
$1.73M
↓ 3.25% YoY
As of Sep 30, 2017
Annual R&D Expenses (TTM)
$8.34M
↑ 41.15% YoY
Trailing 12 months ending Sep 30, 2017
PhaseRx OverviewResearch & Development expenses for PZRXQ.
As of Sep 30, 2017
Trailing 12 months ending Sep 30, 2017